Skip to content

Effect of lidocaine on neuromuscular blockade by mivacurium chloride:a prospective, randomized, controlled, double-blind clinical study

Effect of lidocaine on neuromuscular blockade by mivacurium chloride

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079619
Enrollment
Unknown
Registered
2024-01-08
Start date
2024-01-08
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ureteral /kidney calculi

Interventions

lidocaine group:Lidocaine was given 1.5 mg·kg-1 lidocaine at the time of anesthesia induction
normal saline group:Normal saline was administered intravenously during induction

Sponsors

The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Prior to the initiation of any trial-related activities, the subject shall obtain informed consent, fully understand the purpose and significance of the trial, and be willing to comply with the trial protocol; 2) patients aged 18-60 years; 3) American Society of Anesthesiologists (ASA) grade I-II; 4) subjects undergoing transurethral ureteropelvic laser lithotripsy general anesthesia; 5)body mass index of 19-25 kg/m2.

Exclusion criteria

Exclusion criteria: 1) Difficult airway and severe respiratory diseases, acute respiratory infections, uncontrolled asthma and unexplained dyspnea; 2) Subjects with mental system diseases and cognitive dysfunction and a history of epilepsy; 3) Subjects with cardiovascular diseases (such as congenital heart disease, bradycardia requiring treatment, hypotension requiring treatment, etc.); 4) Subjects with abnormal liver function, alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) exceeding 1.5 times the upper limit of normal; Subjects whose total bilirubin exceeds the upper limit of normal; Subjects with abnormal renal function and blood creatinine exceeding the upper limit of normal; 5) Abnormal plasma cholinesterase activity or pseudocholinesterase deficiency; 6) Participated in other clinical trials (received experimental drug or placebo) within 3 months before surgery; 7) Long-term use of drugs that affect muscle nerve conduction and allergic to narcotic drugs; 8) Other conditions deemed unsuitable for participation in this clinical trial by the investigator. 9) The method of anesthesia was changed.

Design outcomes

Primary

MeasureTime frame
the onset time;train–of–four recover to 25 %;recovery index;

Secondary

MeasureTime frame
vital signs;General information included age, sex, body mass index, and duration of surgery;Coughing, body movement, laryngeal spasm and bronchospasm during laryngeal mask placement;Incidence of skin flushing and decreased blood pressure;

Countries

China

Contacts

Public ContactShangguan Wangning

Wenzhou Medical University Affiliated Stomatological Hospital

sgwning@163.com+86 135 8763 7891

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026